Serotonin Modulation of Cerebral Glucose Metabolism in Depressed Older Adults

Biological Psychiatry

Volumn 66, Issue 3, 2009, Pages 259-266

  Smith, Gwenn S ^a,b   Kramer, Elisse ^a   Hermann, Carol ^a   Ma, Yilong ^b   Dhawan, Vijay ^b   Chaly, Thomas ^b   Eidelberg, David ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

Aging; citalopram; depression; glucose metabolism; positron emission tomography (PET); selective serotonin reuptake inhibitors; serotonin

Indexed keywords

CITALOPRAM; GLUCOSE; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; BRAIN STEM; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEPRESSION; FEMALE; FRONTAL CORTEX; GLUCOSE METABOLISM; HORMONE RESPONSE; HUMAN; HYPOTHESIS; LEFT HEMISPHERE; LIMBIC CORTEX; MALE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SEROTONINERGIC SYSTEM; SUBICULUM; TEMPORAL CORTEX; THALAMUS;

AGED; BRAIN MAPPING; CEREBRAL CORTEX; CITALOPRAM; DEPRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; GERIATRIC ASSESSMENT; GLUCOSE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 67649388043     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.02.012     Document Type: Article

References (57)

1. Schildkraut J.J. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122 (1965) 509-522
2. Lapin I.P., and Oxenkrug G.F. Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1 (1969) 132-136
3. Reynolds III C.F., Dew M.A., Frank E., Begley A.E., Miller M.D., Cornes C., et al. Effects of age at onset of first lifetime episode of recurrent major depression on treatment response and illness course in elderly patients. Am J Psychiatry 155 (1998) 795-799
4. Reynolds III C.F., Frank E., Dew M.A., Houck P.R., Miller M., Mazumdar S., et al. Treatment of 70(+)-year-olds with recurrent major depression. Excellent short-term but brittle long-term response. Am J Geriatr Psychiatry 7 (1999) 64-69
5. Conwell Y., Duberstein P., and Cox C. Relationships of age and Axis I diagnoses in victims of completed suicide: A psychological autopsy study. Am J Psychiatry 153 (1996) 1001-1008
6. Thomas A.J., Gallagher P., Robinson L.J., Porter R.J., Young A.H., Ferrier I.N., and O'Brien J.T. A comparison of neurocognitive impairment in younger and older adults with major depression. Psychol Med 30 (2008) 1-9
7. Krishnan K.R., Hays J.C., Tupler L.A., George L.K., and Blazer D.G. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry 152 (1995) 785-788
8. Alexopoulos G.S., Vrontou C., Kakuma T., Meyers B.S., Young R.C., Klausner E., et al. Disability in geriatric depression. Am J Psychiatry 153 (1996) 877-885
9. Bruce M.L., and Leaf P.J. Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health 79 (1989) 727-730
10. Smith G.S., Gunning-Dixon F.M., Lotrich F.E., Taylor W.D., and Evans J.D. Translational research in late-life mood disorders: Implications for future intervention and prevention research. Neuropsychopharmacology 32 (2007) 1857-1875
11. Smith G.S., Koppel J., and Goldberg S. Applications of neuroreceptor imaging to psychiatry research. Psychopharmacol Bull 37 (2003) 26-65
12. Wu J.C., Gillin J.C., Buchsbaum M.S., Schachat C., Darnall L.A., Keator D.B., et al. Sleep deprivation PET correlations of Hamilton symptom improvement ratings with changes in relative glucose metabolism in patients with depression. J Affect Disord 107 (2008) 181-186
13. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65 (2003) 193-207
14. Smith G., Reynolds C., Pollock B., Derbyshire S., Nofzinger E., Dew M., et al. Acceleration of the cerebral glucose metabolic response to antidepressant treatment by total sleep deprivation in geriatric depression. Am J Psychiatry 156 (1999) 683-689
15. Smith G.S., Reynolds III C.F., Houck P.R., Dew M.A., Ma Y., Mulsant B.H., et al. Glucose metabolic response to total sleep deprivation, recovery sleep, and acute antidepressant treatment as functional neuroanatomic correlates of treatment outcome in geriatric depression. Am J Geriatr Psychiatry 10 (2002) 561-567
16. Mann J.J., Malone K.M., Diehl D.J., Perel J., Cooper T.B., and Mintun M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 153 (1996) 174-182
17. Anderson A.D., Oquendo M.A., Parsey R.V., Milak M.S., Campbell C., and Mann J.J. Regional brain responses to serotonin in major depressive disorder. J Affect Disord 82 (2004) 411-417
18. Bremner J.D., Vythilingam M., Ng C.K., Vermetten E., Nazeer A., Oren D.A., et al. Regional brain metabolic correlates of alpha-methylparatyrosine-induced depressive symptoms: Implications for the neural circuitry of depression. JAMA 18 (2003) 3125-3134
19. Smith G., Ma Y., Dhawan V., Gunduz H., Carbon M., Kirshner M., et al. Serotonin modulation of cerebral glucose metabolism measured with positron emission tomography (PET) in human subjects. Synapse 45: (2002) 105-112
20. Smith G.S., Kramer E., Hermann C.R., Goldberg S., Ma Y., Dhawan V., et al. Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression. Am J Geriatr Psychiatry 10 (2002) 715-723
21. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., and Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biol Psychiatry 48 (2000) 830-843
22. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., and Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiatry 41 (1997) 15-22
23. Raap D.K., and Van de Kar L.D. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci 65 (1999) 1217-1235
24. Goldberg S., Smith G., Ma Y., Kramer E., Pollock B., and Eidelberg D. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging 25 (2004) 167-174
25. First M., Spitzer R., Gibbon M., and Williams J. Structured Clinical Interview for DSM-IV Axis 1 Disorders-Patient Edition (SCID-I/P) (1995), New York Psychiatric Institute, New York
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
27. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
28. Beck A.T., Steer R.A., Ball R., and Ranieri W.F. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67 (1996) 588-597
29. Yesavage J.A. Geriatric Depression Scale. Psychopharmacol Bull 24 (1988) 709-711
30. Kapitany T., Schindl M., Schindler S., Henelmann B., Fureder T., Barnas C., et al. The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 88 (1999) 75-88
31. Takikawa S., Dhawan V., Spetsieris P., Robeson W., Chaly T., Dahl R., et al. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 188 (1993) 131-136
32. In: Friston K.J., Ashburner J., Kiebel S.J., Nichols T.E., and Penny W.D. (Eds). Statistical Parametric Mapping: The Analysis of Functional Brain Images (2007), Elsevier/Academic Press, Amsterdam; Boston
33. Bartlett E.J., Brodie J.D., Wolf A.P., Christman D.R., Laska E., and Meissner M. Reproducibility of cerebral glucose metabolic measurements in resting human subjects. J Cereb Blood Flow Metab 8 (1988) 502-512
34. Alexopoulos G.S., Murphy C.F., Gunning-Dixon F.M., Latoussakis V., Kanellopoulos D., and Klimstra S. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 165 (2008) 238-244
35. Alexopoulos G.S., Murphy C.F., Gunning-Dixon F.M., Kalayam B., Katz R., Kanellopoulos D., et al. Event-related potentials in an emotional go/no-go task and remission of geriatric depression. Neuroreport 18 (2007) 217-221
36. Cavanna A.E., and Trimble M.R. The precuneus: A review of its functional anatomy and behavioural correlates. Brain 129 (2006) 564-568
37. Bhalla R.K., Butters M.A., Mulsant B.H., Begley A.E., Zmuda M.D., Schoderbek B., et al. Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry 14 (2006) 419-427
38. Nebes R.D., Pollock B.G., Houck P.R., Butters M.A., Mulsant B.H., Zmuda M.D., et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: A randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 37 (2003) 99-108
39. Vogt B.A., Vogt L., and Laureys S. Cytology and functionally correlated circuits of human posterior cingulate areas. Neuroimage 29 (2006) 452-466
40. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., and Shulman G.L. A default mode of brain function. Proc Natl Acad Sci U S A 98 (2001) 676-682
41. Buckner R.L., and Vincent J.L. Unrest at rest: Default activity and spontaneous network correlations. Neuroimage 37 (2007) 1091-1096
42. Mohedano-Moriano A., Pro-Sistiaga P., Arroyo-Jimenez M.M., Artacho-Pérula E., Insausti A.M., Marcos P., et al. Topographical and laminar distribution of cortical input to the monkey entorhinal cortex. J Anat 211 (2007) 250-260
43. Stefanacci L., and Amaral D.G. Some observations on cortical inputs to the macaque monkey amygdala: An anterograde tracing study. J Comp Neurol 451 (2002) 301-323
44. Dejardin S., Dubois S., Bodart J.M., Schiltz C., Delinte A., Michel C., et al. Study of human voluntary saccadic eye movements in darkness: Effect of task repetition on the activation pattern. Eur J Neurosci 10 (1998) 2328-2336
45. Kertzman C., Schwarz U., Zeffiro T.A., and Hallett M. The role of posterior parietal cortex in visually guided reaching movements in humans. Exp Brain Res 114 (1997) 170-183
46. Wang L., Krishnan K.R., Steffens D.C., Potter G.G., Dolcos F., and McCarthy G. Depressive state- and disease-related alterations in neural responses to affective and executive challenges in geriatric depression. Am J Psychiatry 165 (2008) 863-871
47. de Asis J.M., Stern E., Alexopoulos G.S., Pan H., Van Gorp W., Blumberg H., et al. Hippocampal and anterior cingulate activation deficits in patients with geriatric depression. Am J Psychiatry 158 (2001) 1321-1323
48. Aizenstein H.J., Butters M.A., Figurski J.L., Stenger V.A., Reynolds III C.F., and Carter C.S. Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 58 (2005) 290-296
49. Brassen S., Kalisch R., Weber-Fahr W., Braus D.F., and Büchel C. Ventromedial prefrontal cortex processing during emotional evaluation in late-life depression: A longitudinal functional magnetic resonance imaging study. Biol Psychiatry 64 (2008) 349-355
50. Grön G., Bittner D., Schmitz B., Wunderlich A.P., and Riepe M.W. Subjective memory complaints: Objective neural markers in patients with Alzheimer's disease and major depressive disorder. Ann Neurol 51 (2002) 491-498
51. Hinz R., Selvaraj S., Murthy N.V., Bhagwagar Z., Taylor M., Cowen P.J., et al. Effects of citalopram infusion on the serotonin transporter binding of [(11)C]DASB in healthy controls. J Cereb Blood Flow Metab 28 (2008) 1478-1490
52. Kreiss D.S., Wieland S., and Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience 52 (1993) 295-301
53. Invernizzi R., Velasco C., Bramante M., Longo A., and Samanin R. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36 (1997) 467-473
54. Golembiowska K., and Dziubina A. Effect of acute and chronic administration of citalopram on glutamate and aspartate release in the rat prefrontal cortex. Pol J Pharmacol 52 (2000) 441-448
55. De Lucas G., Deurwaerdere P., Porras G., and Spampinato U. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated. Neuropharmacology 39 (2000) 1984-1995
56. Hilgert M., Buchholzer M., Jeltsch H., Kelche C., Cassel J.C., and Klein J. Serotonergic modulation of hippocampal acetylcholine release after long-term neuronal grafting. Neuroreport 11 (2000) 3063-3065
57. Smith G., Ma Y., Dhawan V., Chaly T., Belakhleff A., and Eidelberg D. Selective serotonin reuptake inhibitor (SSRI) modulation of striatal dopamine measured with [11C]-raclopride and positron emission tomography. Synapse 63 (2009) 1-6